Abstract

Corneal scarring associated with various corneal conditions is a leading cause of blindness worldwide. The present study aimed to test the hypothesis that corneal stromal stem cells have a therapeutic effect and are able to restore the extracellular matrix organization and corneal transparency in vivo. We first developed a mouse model of corneal stromal scar induced by liquid nitrogen (N2) application. We then reversed stromal scarring by injecting mouse or human corneal stromal stem cells in injured cornea. To characterize the mouse model developed in this study and the therapeutic effect of corneal stromal stem cells, we used a combination of in vivo (slit lamp, optical coherence tomography, in vivo confocal microscopy, optical coherence tomography shear wave elastography, and optokinetic tracking response) and ex vivo (full field optical coherence microscopy, flow cytometry, transmission electron microscopy, and histology) techniques. The mouse model obtained features early inflammation, keratocyte apoptosis, keratocyte transformation into myofibroblasts, collagen type III synthesis, impaired stromal ultrastructure, corneal stromal haze formation, increased corneal rigidity, and impaired visual acuity. Injection of stromal stem cells in N2‐injured cornea resulted in improved corneal transparency associated with corneal stromal stem cell migration and growth in the recipient stroma, absence of inflammatory response, recipient corneal epithelial cell growth, decreased collagen type III stromal content, restored stromal ultrastructure, decreased stromal haze, decreased corneal rigidity, and improved vision. Our study demonstrates the ability of corneal stromal stem cells to promote regeneration of transparent stromal tissue after corneal scarring induced by liquid nitrogen.

Details

Title
Corneal stromal stem cells restore transparency after N 2 injury in mice
Author
Ghoubay, Djida 1   VIAFID ORCID Logo  ; Borderie, Marie 2 ; Grieve, Kate 3 ; Martos, Raphaël 4 ; Bocheux, Romain 5 ; Thu‐Mai Nguyen 6 ; Callard, Patrice 7 ; Chédotal, Alain 3 ; Borderie, Vincent M 1   VIAFID ORCID Logo 

 Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France; Centre Hospitalier National d'Ophtalmologie des 15‐20, DHU Sight Restore, INSERM‐DHOS CIC, Paris, France 
 Centre Hospitalier National d'Ophtalmologie des 15‐20, DHU Sight Restore, INSERM‐DHOS CIC, Paris, France 
 Institut de la Vision, Sorbonne Université, INSERM, CNRS, Paris, France 
 Laboratoire de Recherche Vasculaire Translationnelle, INSERM U1148, Université Paris Diderot, Sorbonne Paris Cité, Paris, France 
 Laboratoire d'Optique et Biosciences (LOB) École polytechnique, CNRS UMR 7645, INSERM U 1182, Palaiseau cedex, France 
 Institut Langevin Ondes et images CNRS UMR 7587, INSERM U979 Physiques des ondes pour la médecine, ESPCI, Paris, France 
 Sorbonne Université, APHP, Hôpital Pitié Salpêtrière, Paris, France 
Pages
917-935
Section
TISSUE‐SPECIFIC PROGENITOR AND STEM CELLS
Publication year
2020
Publication date
Aug 2020
Publisher
Oxford University Press
ISSN
21576564
e-ISSN
21576580
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2426748023
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.